The price trends of HIV/AIDS medicines: Finding and using data Dr. Perriëns Joseph Coordinator SSH Unit, WHO.

Slides:



Advertisements
Similar presentations
THE CHALLENGES & OPORTUNITIES OF ACCESS TO MEDICINES IN AFRICA Dr Pascoal MOCUMBI, orig Mozambique,High Representative EDCTP ABRASCO/WFPHA.
Advertisements

2 nd line and recent ARVs prices and access issues Carmen Pérez Casas Access Campaign MSF May 2006.
MDG Target 8.E gap analysis Ms. Alexandra Cameron Department of Essential Medicines and Pharmaceutical Policies, World Health Organization 27 August 2008.
Price Reporting Mechanism (PRM): Lessons learnt and how to use the evidence from the PRM Technical Briefing Seminar for Consultants on Procurement and.
National PSM Coordination Mechanism Dr Vincent Habiyambere WHO/HIV Department AIDS Medicines & Diagnostics Service (AMDS) Bangkok, July 2005.
AMDS Contribution to the Technical Briefing Seminar October 2007.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
Public ARV Procurement Data: Using Information to Obtain Lower Prices Brenda Waning March 6, 2008 Open Society Institute Seminar Kiev, Ukraine Funded by.
WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies
The Medicines Patent Pool advancing innovation, expanding access, promoting public health Charles Clift Chair, Medicines Patent Pool
25 Years of Essential Medicines Jonathan D. Quick, MD, MPH Hans V. Hogerzeil, MD, PhD WHO Essential Drugs and Medicines Policy May 2002.
IPC meeting June 2014 Dr Joelle DAVIAUD, Quality Assurance Specialist Model Quality Assurance System for procurement agencies.
Update to IPC on MODEL QUALITY ASSURANCE SYSTEM FOR PROCUREMENT AGENCIES (MQAS) Dr Sabine Kopp 16 December 2014 Update to IPC on MODEL QUALITY ASSURANCE.
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
Affordability of HIV/AIDS treatment in developing countries: modeling ARV drug price determinants for a better understanding of the market functioning.
Access to ARVs in low and middle income countries - Joseph Perriëns Coordinator HIV technology and commodities HIV dept. World Health Organization.
1 Intellectual Property Rights in Medicines Procurement Patrick Osewe Senior HIV/AIDS Specialist World Bank.
A very short introduction to patents & access to medicines.
Iman Wanis, Cushla Coffey, Shaffiq Essajee, and Philippa Easterbrook World Health Organization, HIV Department (ATC) Geneva, Switzerland July 2011 COSTING.
Overcoming the HIV/AIDS Epidemic in Ukraine Key issues for the Consolidation Group A National programme supported by the Global Fund.
Department of Technical Cooperation for Essential Drugs and Traditional Medicine (TCM) Roles and responsibilities in implementing the WHO Medicines Strategy.
Capacity Development – Haïti case study PMU May HAITI Program Management Unit Global Fund.
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
Pharmacology & Prescribing Essential Drugs: Practical Guidelines International Drug Price Indicator Guide Merck Manuals WHO Model List of Essential Drugs.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
WHO-HIV Department Strategic Information Unit AIDS Medicines and Diagnostics Service Contribution to Access to medicines Technical Briefing Seminar, November.
CO “All-Ukrainian Network of People Living with HIV” Potential Problems in Supply – What Can Be Done? Kyiv, 2008.
From 3by5 to Universal Access to HIV/AIDS Treatment: AMDS Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and.
Lessons learned from the Global Fund’s Price and Quality Reporting (PQR) database T Patrick Aylward, Sophie Logez, Thuy Huong Ha, Monika Zweygarth, Carmen.
Selection of essential medicines Suzanne Hill September 2006 Department of Medicines Policy and Standards TBS 2006.
Affordability of HIV/AIDS treatment in developing countries: an analysis of ARV drug price determinants Luis Sagaon Teyssier; Yves Arrighi; Boniface Dongmo.
AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics J. Perriëns.
CLICK TO ADD TITLE [DATE][SPEAKERS NAMES] The 5th Global Health Supply Chain Summit November , 2013 Addis Ababa, Ethiopia Country-level Coordinated.
World Health Organization "3 by 5" Target Treat 3 million by 2005.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
Overview of the AMDS Products
World Health Organization "3 by 5" Target Access to HIV/AIDS Medicines The 3x5 strategy WHO/EDM Technical Briefing Seminar.
Simplification and Harmonization - Update UNDAF results matrix: feed back from roll out countries Joint Programming.
Washington D.C., USA, July 2012www.aids2012.org An advocacy tool: Untangling the Web of Antiretroviral Price Reductions Arax Bozadjian HIV Focused.
AMDS Clearing House Dr Jos Perriens Coordinator TCO Unit/HIV, WHO.
Access to medicines challenges in Europe: What is wrong and the way forward Presented by: Rohit Malpani Director of Policy & Analysis, Access Campaign.
UNITAID actions and main achievements Investing in the quality of medicines XVII International AIDS Conference Satellite Forum WHO – Essential Medicines.
Global Fund Work on HIV/SRH Linkages 09 March 2015 Olga Bornemisza New York, USA IAWG Meeting on HIV/SRH Linkages.
Moving towards a Patent Pool? XVII International AIDS Conference Satellite Forum, MSF, KEI, OXFAM (Mexico, 5 August 2008) Jorge Bermudez Executive-Secretary,
How Advocacy can Influence Pricing & Policy
WHO Global Price Reporting Mechanism, the importance of data registration for the regulation of antiretrovirals (ARV) and PSM issues related to access.
Making medicines, diagnostics and other commodities more affordable
IDA Solutions Clarisse Morris, MA January 2006
Global Drug Facility An innovative approach to supplying anti-TB drugs
Figure 1 Flowchart data extraction and cleaning process from the Global Price Reporting Mechanism in 2008 for the countries studied. From: Allocating scarce.
Expanding ARV treatment in developing countries: Issues and Prospects
Review of integrated PSM resources and tools and introduction to group work Upjeet Chandan ICCM FTT 17th February 2016.
WHO Essential Drugs and Medicines Policy
Access framework HIV/AIDS, TB and Malaria
World Health Organization
World Health Organization
World Health Organization
"3 by 5" progress December 2005.
B. Dongmo Nguimfack AMDS TCO Unit/HIV, WHO
22nd International AIDS Conference Amsterdam, 24 July 2018
Role of Contracting and Procurement Services in WHO
AMDS Products, events and issues.
برنامج التميز في خدمة عملاء السادة موظفي مكاتب المساعدة القانونية
Access to HIV/AIDS Medicines The 3x5 strategy
WHO Essential Drugs and Medicines Policy
Consolidated Technical Support Plan for AIDS
Product selection issues
Guide to Writing The Procurement and Supply Management Plan
WHO Global HIV/AIDS Staff Meeting
Access to Essential Medicines
Presentation transcript:

The price trends of HIV/AIDS medicines: Finding and using data Dr. Perriëns Joseph Coordinator SSH Unit, WHO

Tools and reports on Pricing Sources and Prices of Selected Medicines and Diagnostics for People Living with HIV/AIDS Untangling the web of price reductions - MSF AFRO Essential Medicines Price Indicator Measuring medicine Prices, availability, affordability and price components International Drug Price Indicator Guide Price Reporting Mechanism (GF) Global Price Reporting Mechanism

Procurement information comes from: CHAI/UNITAID Crown Agent IAPSO UNDP IDA HIV/AIDS MissionPharma UNICEF GPRM Global Fund USAID/Deliver MSH SCMS WHO CPS UNFPA Countries

Countries Over 100 countries covered

Procurement information comes from: CHAI/UNITAID Crown Agent IAPSO UNDP IDA HIV/AIDS MissionPharma Unicef GPRM Global Fund JSI/Deliver MSH SCMS WHO CPS UNFPA GRPM captures in 2007 around 60% of ARV transactions in low and middle income countries

Median price of the most common used 1st line regimens in low income countries

Median price of the most common used 1st line regimens in middle income countries

Median price of the most common used 2nd line regimens in low income countries

Median price of the most common used 2nd line regimens in middle income countries

GPRM data are in the public domain Searches are possible: by formulation or product by year by country or group of countries and can be downloaded in Excel or as a.pdf file

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.